SMTL ID : 4ayt.1

STRUCTURE OF THE HUMAN MITOCHONDRIAL ABC TRANSPORTER, ABCB10

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.85 Å

Oligo State

homo-dimer

Ligands

2 x GLY: GLYCINE(Non-covalent)

GLY.1: 4 residues within 4Å: Chain A: R.20, Y.84, R.92 Chain B: R.239 4 PLIP interactions: 3 interactions with chain A, 1 interactions with chain B Hydrogen bonds: A:Y.84 Salt bridges: A:R.20, A:R.92 Water bridges: B:R.239 GLY.9: 4 residues within 4Å: Chain A: R.239 Chain B: R.20, Y.84, R.92 3 PLIP interactions: 3 interactions with chain B Water bridges: B:Y.84 Salt bridges: B:R.20, B:R.92

2 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 4 residues within 4Å: Chain A: S.384, Q.425, D.508 Ligands: ACP.3 1 PLIP interactions: 1 interactions with chain A Metal complexes: A:S.384 MG.10: 4 residues within 4Å: Chain B: S.384, Q.425, D.508 Ligands: ACP.11 1 PLIP interactions: 1 interactions with chain B Metal complexes: B:S.384

2 x ACP: PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER(Non-covalent)

ACP.3: 14 residues within 4Å: Chain A: D.114, Y.351, A.353, I.359, S.379, G.380, S.381, G.382, K.383, S.384, T.385, Y.394, Q.425 Ligands: MG.2 14 PLIP interactions: 14 interactions with chain A Hydrogen bonds: A:D.114, A:R.354, A:G.380, A:S.381, A:G.382, A:G.382, A:K.383, A:K.383, A:S.384, A:S.384, A:T.385, A:Q.425 pi-Stacking: A:Y.351, A:Y.351 ACP.11: 14 residues within 4Å: Chain B: D.114, Y.351, A.353, I.359, S.379, G.380, S.381, G.382, K.383, S.384, T.385, Y.394, Q.425 Ligands: MG.10 15 PLIP interactions: 15 interactions with chain B Hydrogen bonds: B:D.114, B:R.354, B:G.380, B:S.381, B:G.382, B:G.382, B:K.383, B:K.383, B:S.384, B:S.384, B:T.385, B:T.385, B:Q.425 pi-Stacking: B:Y.351, B:Y.351

6 x LMT: DODECYL-BETA-D-MALTOSIDE(Non-covalent)

LMT.4: 14 residues within 4Å: Chain A: D.47, Y.50, T.51, L.264, G.268, M.271, G.272, T.277, V.278 Chain B: I.49, P.53, L.61, L.64, L.68 9 PLIP interactions: 5 interactions with chain B, 4 interactions with chain A Hydrophobic interactions: B:I.49, B:I.49, B:L.61, B:L.64, B:L.68, A:L.264 Hydrogen bonds: A:D.47, A:D.47, A:V.278 LMT.6: 6 residues within 4Å: Chain A: A.288, V.291, G.292, I.295, G.296, S.299 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:V.291, A:I.295, A:I.295 LMT.7: 14 residues within 4Å: Chain A: N.163, F.167, V.171, V.175, S.255, I.259, S.262, Y.265, K.266, L.269, L.270, S.273, H.275 Ligands: CDL.5 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:F.167, A:V.171, A:V.175, A:I.259, A:Y.265, A:K.266 Hydrogen bonds: A:N.163, A:K.266, A:S.273 Water bridges: A:H.275 Salt bridges: A:K.266 LMT.12: 14 residues within 4Å: Chain A: I.49, P.53, L.61, L.64, L.68 Chain B: D.47, Y.50, T.51, L.264, G.268, M.271, G.272, T.277, V.278 8 PLIP interactions: 5 interactions with chain A, 3 interactions with chain B Hydrophobic interactions: A:I.49, A:I.49, A:L.61, A:L.64, A:L.68, B:L.264 Hydrogen bonds: B:D.47, B:V.278 LMT.14: 6 residues within 4Å: Chain B: A.288, V.291, G.292, I.295, G.296, S.299 3 PLIP interactions: 3 interactions with chain B Hydrophobic interactions: B:V.291, B:I.295, B:I.295 LMT.15: 14 residues within 4Å: Chain B: N.163, F.167, V.171, V.175, S.255, I.259, S.262, Y.265, K.266, L.269, L.270, S.273, H.275 Ligands: CDL.13 10 PLIP interactions: 10 interactions with chain B Hydrophobic interactions: B:F.167, B:V.171, B:V.175, B:I.259, B:Y.265, B:K.266 Hydrogen bonds: B:N.163, B:K.266, B:S.273 Salt bridges: B:K.266

4 x CDL: CARDIOLIPIN(Non-covalent)

CDL.5: 16 residues within 4Å: Chain A: F.158, P.162, N.163, T.166, F.167, L.169, S.170, V.171, V.175, I.178, A.179, Y.182, A.251, S.255, K.266 Ligands: LMT.7 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:F.158, A:F.158, A:P.162, A:L.169, A:V.171, A:V.175, A:I.178, A:A.179, A:Y.182, A:A.251 Hydrogen bonds: A:N.163, A:T.166 Salt bridges: A:K.266 CDL.8: 6 residues within 4Å: Chain A: F.41, L.42, L.64, F.72 Chain B: N.257, V.260 5 PLIP interactions: 3 interactions with chain A, 2 interactions with chain B Hydrophobic interactions: A:F.41, A:L.42, A:F.72, B:V.260, B:V.260 CDL.13: 16 residues within 4Å: Chain B: F.158, P.162, N.163, T.166, F.167, L.169, S.170, V.171, V.175, I.178, A.179, Y.182, A.251, S.255, K.266 Ligands: LMT.15 12 PLIP interactions: 12 interactions with chain B Hydrophobic interactions: B:F.158, B:F.158, B:P.162, B:L.169, B:V.171, B:V.175, B:I.178, B:A.179, B:Y.182, B:A.251 Hydrogen bonds: B:N.163 Salt bridges: B:K.266 CDL.16: 6 residues within 4Å: Chain A: N.257, V.260 Chain B: F.41, L.42, L.64, F.72 5 PLIP interactions: 3 interactions with chain B, 2 interactions with chain A Hydrophobic interactions: B:F.41, B:L.42, B:F.72, A:V.260, A:V.260

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Shintre, C.A. et al., Structures of Abcb10, a Human ATP-Binding Cassette Transporter in Apo- and Nucleotide-Bound States. Proc.Natl.Acad.Sci.USA (2013)

Release Date

2012-07-11

Peptides

ATP-BINDING CASSETTE SUB-FAMILY B MEMBER 10 MITOCHONDRIAL: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

Membrane

We predict this structure to be a membrane protein.
Show / Hide

ATP-BINDING CASSETTE SUB-FAMILY B MEMBER 10 MITOCHONDRIAL

Related Entries With Identical Sequence